Demographic data of genotypes, everolimus level in patients with tuberous sclerosis complex-associated renal angiomyolipoma (TSC-AML)
| Patient, n | Age (years) | Gender | Gene | Body weight (kg) | Dose (μg/kg/ day) | Mean trough | |
| (mg/day) | (μg/kg/day) | level (ng/mL) | |||||
| 1 | 14 | M | TSC2 | 80 | 2.5 | 31 | 3.14 |
| 2 | 20 | F | TSC2 | 54 | 46 | 2.2 | |
| 3 | 22 | F | ND | 55 | 45 | 1.5 | |
| 4 | 27 | F | TSC1 | 62 | 40 | 7.7 | |
| 5 | 24 | F | TSC2 | 41 | 61 | 2.0 | |
| 6 | 26 | F | TSC2 | 53 | 5.0 | 94 | 8.3 |
| 7 | 31 | F | TSC1 | 49 | 100 | 15.4 | |
| 8 | 39 | F | TSC2 | 64 | 78 | 13.9 | |
| 9 | 44 | F | TSC1 | 58 | 86 | 11.7 | |
| 10 | 17 | F | TSC2 | 52 | 96 | 2.0 | |
| 11 | 13 | F | ND | 69 | 72 | 9.0 | |
F, female; M, male; ND, not done/not identified.